Skip to main navigation
Skip to search
Skip to main content
Luxembourg Institute of Health Home
Search content at Luxembourg Institute of Health
Home
Profiles
Research units
Research output
Projects
Equipment
Datasets
Natural chalcones as dual inhibitors of HDACs and NF-κB
B. Orlikova
,
M. Schnekenburger
, M. Zloh
, F. Golais
, M. Diederich
*
, D. Tasdemir
*
Corresponding author for this work
Research output
:
Contribution to journal
›
Article
›
Research
›
peer-review
87
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Natural chalcones as dual inhibitors of HDACs and NF-κB'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Anti-inflammatory Effect
12%
Antitumor Effect
12%
Biological Targets
12%
Butein
12%
Chalcone
62%
Dual Activity
12%
Dual Inhibitor
100%
Enzyme Activity
12%
Enzyme Inhibitory Activity
25%
Fluorescence Assay
12%
Glycosides
12%
Histone Deacetylase Enzymes
100%
Histone Deacetylase Inhibitor (HDACi)
100%
IC50 Value
25%
Inflammation
25%
Inhibitory Potential
25%
Isoliquiritigenin
12%
Marein
12%
Molecular Docking Studies
12%
Molecular Modeling Studies
12%
Natural Chalcones
100%
Natural Products
12%
NF-B
100%
Putative Drug Targets
12%
Structure-activity Relationship
12%
Transcription Factor
12%
Pharmacology, Toxicology and Pharmaceutical Science
Anti-Inflammatory Drug
12%
Biological Target
12%
Butein
12%
Chalcone Derivative
100%
Enzymes
100%
Fluorescence Assay
12%
Glycoside
12%
Histone Deacetylase
100%
IC50
25%
Inflammation
25%
Isoliquiritigenin
12%
Lead Compound
12%
Malignant Neoplasm
25%
Natural Product
12%
Structure Activity Relationship
12%
Transcription Factors
12%
Tumor Necrosis Factor
25%
Biochemistry, Genetics and Molecular Biology
Anti-Inflammatory
12%
Biological Target
12%
Enzyme
100%
Enzyme Activity
12%
Fluorescence Assay
12%
Glycoside
12%
Histone Deacetylase
100%
IC50
25%
Molecular Model
12%
Structure Activity Relation
12%
Transcription Factors
12%
Tumor Necrosis Factor
25%